Live Pain Free
Nerve Regeneration Formula - Peripheral Neuropathy Supplement
Nerve Regeneration Formula - Peripheral Neuropathy Supplement
Nerve Regeneration Formula - Peripheral Neuropathy Supplement
Roll over to zoom in + View large image

Nerve Regeneration Formula - Peripheral Neuropathy Supplement

    • SUPPORTS HEALTHY NERVE REGENERATION* (ALA + Acetyl L-Carnitine + Benfotiamine)
    • SUPPORTS HEALTHY NERVE CIRCULATION* (Alpha Lipoic Acid)
    • NOURISHES & ENERGIZES NERVES* (Acetyl L-Carnitine + CoQ10)
    • SUPPORTS HEALTHY NERVE SIGNALING* (Benfotiamine + Magnesium)
PRODUCT CODE: NRF100

DESCRIPTION

Made in the USA Icon Third Party Tested for Purity and Potency Icon cGMP Certified Current Good Manufacturing Practices Icon Heavy Metals Tested Icon 100 Percent No Artificial Dyes Coloring Sweeteners Icon

The Nerve Regeneration Formula: Science-Led Nutritional Support for Peripheral Nerve Function*

Peripheral nerve integrity depends on mitochondrial ATP generation, balanced redox signaling, and regulated metabolic pathways—physiological domains frequently influenced in neuropathy-related contexts. Clinicians managing peripheral nerve stress commonly encounter manifestations such as altered sensation, nerve conduction slowing, and metabolic dysregulation. The Nerve Regeneration Formula is a clinician-developed formulation designed for daily use to reinforce these convergent biological pathways using well-studied nutrient cofactors.*


Formulation Strategy: Convergent Pathway Support

The formulation integrates mitochondrial cofactors, redox modulators, and metabolic regulators to support nerve-related physiological systems identified in clinical research.

  • Mitochondrial Bioenergetics: Acetyl L-Carnitine (500 mg) contributes to mitochondrial substrate transport and cellular energy output, supporting neuronal signaling resilience. Coenzyme Q10 (60 mg) supports electron transport chain function essential for ATP production.
  • Redox Regulation & Antioxidant Recycling: Through its role in cellular redox cycling, R-Alpha Lipoic Acid (400 mg) has been studied for its ability to support intracellular antioxidant balance. N-Acetyl Cysteine (300 mg) supports glutathione synthesis pathways central to oxidative regulation.
  • Metabolic Pathway Support: Benfotiamine (200 mg) supports transketolase activity within the pentose phosphate pathway, relevant to cellular responses to glucose-derived intermediates.
  • Neuroinflammatory Signaling Modulation: Curcumin Extract (95% Curcuminoids) has been studied for its antioxidant properties and modulation of inflammatory signaling pathways.
  • Micronutrient Cofactor Support: Magnesium (from glycinate) and Zinc (as zinc L-carnosine) provide enzymatic cofactors involved in neuromuscular transmission and membrane stability.

Dosing & Administration

Serving Size: 1 scoop (8 g) daily
Servings Per Bottle: 30 (240 g total)

Designed for consistent daily use as part of a comprehensive peripheral nerve support strategy.


Formulation Standards

  • Third-party laboratory tested for heavy metals and label potency
  • No artificial dyes, flavors, or synthetic sweeteners
  • Naturally flavored Strawberry Lemonade drink powder
  • Manufactured in the USA in GMP-compliant facilities

Selected Clinical Research Context

The nutrient components within this formulation have been evaluated in controlled human trials examining neuropathy-related endpoints.

R-Alpha Lipoic Acid
Evaluated in randomized controlled trials in distal symmetric polyneuropathy populations.
Key study outcomes: neuropathy symptom scores, total symptom score (TSS), nerve conduction parameters, and quality-of-life indices.

  • SYDNEY 2 (Diabetes Care) | NATHAN 1 (Diabetes Care)

    Acetyl L-Carnitine
    Has been studied in randomized controlled trials examining peripheral nerve fiber metrics and conduction outcomes in neuropathy contexts.
    Key study outcomes: nerve fiber density measures, pain scales, and conduction velocity parameters.
    Sima et al. (Diabetes Care)

    Benfotiamine
    Evaluated in controlled clinical research examining metabolic pathway modulation and neuropathy symptom scales in diabetic polyneuropathy populations.
    Key study outcomes: symptom score measures and metabolic pathway markers.
    Stracke et al. (BENDIP STUDY)

    Coenzyme Q10
    Evaluated in randomized controlled research as an adjunct therapy in painful diabetic neuropathy populations.
    Key study outcomes: neuropathic pain score reductions and clinical symptom improvements.
    Hernández-Ojeda et al. (2012) | Amini et al. (Eur J Clin Pharmacol, 2022)


    *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

SPECIFICATIONS

  • Product Weight (lbs) : 1
×